NEW YORK — Consumer health firm Molecular You said on Wednesday that it has raised $5 million in a Series A financing round.

纽约——消费者健康公司Molecular You周三表示，已在A轮融资中筹集了500万美元。

The round was led by Voloridge Health and included Dynamic Leap and other unnamed investors.

本轮融资由Voloridge Health领投，Dynamic Leap和其他未具名投资者参与。

Earlier this year, Molecular You

今年早些时候，Molecular You

launched

启动

a direct-to-consumer blood test designed to analyze over 250 metabolic and proteomic biomarkers to generate risk profiles for around 26 health conditions.

一种直接面向消费者的血液检测，旨在分析250多种代谢和蛋白质组学生物标志物，以生成约26种健康状况的风险概况。

The Vancouver, British Columbia-based company said it will use the Series A funding to grow its consumer and clinical customer base in North America, as well as advance a next-generation test that will measure over 800 biomarkers.

总部位于不列颠哥伦比亚省温哥华的公司表示，将利用A轮融资扩大其在北美的消费者和临床客户群，同时推进一项可测量800多种生物标志物的新一代测试。

Molecular You said that it has recently struck a deal under which reference lab HealthQuest Esoterics runs the assay as a lab-developed test, making it eligible for reimbursement.

分子你提到，它最近达成了一项协议，根据该协议，参考实验室HealthQuest Esoterics将该检测作为实验室开发的测试运行，使其有资格获得报销。